Two-Year Follow Up of the LATERAL Clinical Trial: A Focus on Adverse Events

BACKGROUND: The LATERAL trial validated the safety and efficacy of the thoracotomy approach for implantation of the HeartWare HVAD System, leading to Food and Drug Administration approval. We sought to analyze 24-month adverse event (AE) rates, including a temporal analysis of the risk profile, asso...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Circ Heart Fail
Asıl Yazarlar: Wieselthaler, Georg M., Klein, Liviu, Cheung, Anson W., Danter, Matthew R., Strueber, Martin, Mahr, Claudius, Mokadam, Nahush A., Maltais, Simon, McGee, Edwin C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2021
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8059760/
https://ncbi.nlm.nih.gov/pubmed/33866829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.120.006912
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller